These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
527 related items for PubMed ID: 26541778
1. PET Imaging of VEGFR-2 Expression in Lung Cancer with 64Cu-Labeled Ramucirumab. Luo H, England CG, Graves SA, Sun H, Liu G, Nickles RJ, Cai W. J Nucl Med; 2016 Feb; 57(2):285-90. PubMed ID: 26541778 [Abstract] [Full Text] [Related]
2. A three-time-point method for assessing kinetic parameters of 64Cu-labeled Ramucirumab trapping in VEGFR-2 positive lung tumors. Laffon E, Marthan R. Phys Med; 2017 Nov; 43():1-5. PubMed ID: 29195550 [Abstract] [Full Text] [Related]
3. ImmunoPET Imaging of CD146 in Murine Models of Intrapulmonary Metastasis of Non-Small Cell Lung Cancer. England CG, Jiang D, Hernandez R, Sun H, Valdovinos HF, Ehlerding EB, Engle JW, Yang Y, Huang P, Cai W. Mol Pharm; 2017 Oct 02; 14(10):3239-3247. PubMed ID: 28825843 [Abstract] [Full Text] [Related]
4. PET of c-Met in Cancer with ⁶⁴Cu-Labeled Hepatocyte Growth Factor. Luo H, Hong H, Slater MR, Graves SA, Shi S, Yang Y, Nickles RJ, Fan F, Cai W. J Nucl Med; 2015 May 02; 56(5):758-63. PubMed ID: 25840981 [Abstract] [Full Text] [Related]
5. ImmunoPET for assessing the differential uptake of a CD146-specific monoclonal antibody in lung cancer. Sun H, England CG, Hernandez R, Graves SA, Majewski RL, Kamkaew A, Jiang D, Barnhart TE, Yang Y, Cai W. Eur J Nucl Med Mol Imaging; 2016 Nov 02; 43(12):2169-2179. PubMed ID: 27342417 [Abstract] [Full Text] [Related]
6. PET Imaging of Tissue Factor in Pancreatic Cancer Using 64Cu-Labeled Active Site-Inhibited Factor VII. Nielsen CH, Jeppesen TE, Kristensen LK, Jensen MM, El Ali HH, Madsen J, Wiinberg B, Petersen LC, Kjaer A. J Nucl Med; 2016 Jul 02; 57(7):1112-9. PubMed ID: 27013699 [Abstract] [Full Text] [Related]
7. 64Cu-Labeled Repebody Molecules for Imaging of Epidermal Growth Factor Receptor-Expressing Tumors. Pyo A, Yun M, Kim HS, Kim TY, Lee JJ, Kim JY, Lee S, Kwon SY, Bom HS, Kim HS, Kim DY, Min JJ. J Nucl Med; 2018 Feb 02; 59(2):340-346. PubMed ID: 28916621 [Abstract] [Full Text] [Related]
8. In vivo small-animal PET/CT of EphB4 receptors using 64Cu-labeled peptide. Xiong C, Huang M, Zhang R, Song S, Lu W, Flores L, Gelovani J, Li C. J Nucl Med; 2011 Feb 02; 52(2):241-8. PubMed ID: 21233177 [Abstract] [Full Text] [Related]
9. A tyrosine kinase inhibitor-based high-affinity PET radiopharmaceutical targets vascular endothelial growth factor receptor. Li F, Jiang S, Zu Y, Lee DY, Li Z. J Nucl Med; 2014 Sep 02; 55(9):1525-31. PubMed ID: 24970912 [Abstract] [Full Text] [Related]
10. Immuno-PET of tissue factor in pancreatic cancer. Hong H, Zhang Y, Nayak TR, Engle JW, Wong HC, Liu B, Barnhart TE, Cai W. J Nucl Med; 2012 Nov 02; 53(11):1748-54. PubMed ID: 22988057 [Abstract] [Full Text] [Related]
11. PET Imaging of Abdominal Aortic Aneurysm with 64Cu-Labeled Anti-CD105 Antibody Fab Fragment. Shi S, Orbay H, Yang Y, Graves SA, Nayak TR, Hong H, Hernandez R, Luo H, Goel S, Theuer CP, Nickles RJ, Cai W. J Nucl Med; 2015 Jun 02; 56(6):927-32. PubMed ID: 25883125 [Abstract] [Full Text] [Related]
12. PET imaging of insulin-like growth factor type 1 receptor expression with a 64Cu-labeled Affibody molecule. Su X, Cheng K, Liu Y, Hu X, Meng S, Cheng Z. Amino Acids; 2015 Jul 02; 47(7):1409-19. PubMed ID: 25854877 [Abstract] [Full Text] [Related]
13. Positron emission tomography imaging of vascular endothelial growth factor receptor expression with (61)Cu-labeled lysine-tagged VEGF121. Zhang Y, Hong H, Niu G, Valdovinos HF, Orbay H, Nayak TR, Chen X, Barnhart TE, Cai W. Mol Pharm; 2012 Dec 03; 9(12):3586-94. PubMed ID: 23137334 [Abstract] [Full Text] [Related]
14. A new PET tracer specific for vascular endothelial growth factor receptor 2. Wang H, Cai W, Chen K, Li ZB, Kashefi A, He L, Chen X. Eur J Nucl Med Mol Imaging; 2007 Dec 03; 34(12):2001-10. PubMed ID: 17694307 [Abstract] [Full Text] [Related]
15. PET of vascular endothelial growth factor receptor expression. Cai W, Chen K, Mohamedali KA, Cao Q, Gambhir SS, Rosenblum MG, Chen X. J Nucl Med; 2006 Dec 03; 47(12):2048-56. PubMed ID: 17138749 [Abstract] [Full Text] [Related]
16. Synthesis, preclinical validation, dosimetry, and toxicity of 68Ga-NOTA-anti-HER2 Nanobodies for iPET imaging of HER2 receptor expression in cancer. Xavier C, Vaneycken I, D'huyvetter M, Heemskerk J, Keyaerts M, Vincke C, Devoogdt N, Muyldermans S, Lahoutte T, Caveliers V. J Nucl Med; 2013 May 03; 54(5):776-84. PubMed ID: 23487015 [Abstract] [Full Text] [Related]
17. Homodimeric peptide radiotracer [68Ga]Ga-NOTA-(TMVP1)2 for VEGFR-3 imaging of cervical cancer patients. Chen X, Zhang Z, Wang L, Zhang J, Zhao T, Cai J, Dang Y, Guo R, Liu R, Zhou Y, Wei R, Lou X, Xia F, Ma D, Li F, Dai J, Li F, Xi L. Eur J Nucl Med Mol Imaging; 2024 Jul 03; 51(8):2338-2352. PubMed ID: 38411667 [Abstract] [Full Text] [Related]
18. N-terminal modifications improve the receptor affinity and pharmacokinetics of radiolabeled peptidic gastrin-releasing peptide receptor antagonists: examples of 68Ga- and 64Cu-labeled peptides for PET imaging. Gourni E, Mansi R, Jamous M, Waser B, Smerling C, Burian A, Buchegger F, Reubi JC, Maecke HR. J Nucl Med; 2014 Oct 03; 55(10):1719-25. PubMed ID: 25146125 [Abstract] [Full Text] [Related]
19. Evaluation of 64Cu radiolabeled anti-hPD-L1 Nb6 for positron emission tomography imaging in lung cancer tumor mice model. Jiang J, Zhang M, Li G, Liu T, Wan Y, Liu Z, Zhu H, Yang Z. Bioorg Med Chem Lett; 2020 Feb 15; 30(4):126915. PubMed ID: 31926788 [Abstract] [Full Text] [Related]
20. Evaluation of two novel ⁶⁴Cu-labeled RGD peptide radiotracers for enhanced PET imaging of tumor integrin αvβ₃. Hernandez R, Czerwinski A, Chakravarty R, Graves SA, Yang Y, England CG, Nickles RJ, Valenzuela F, Cai W. Eur J Nucl Med Mol Imaging; 2015 Nov 15; 42(12):1859-68. PubMed ID: 26016906 [Abstract] [Full Text] [Related] Page: [Next] [New Search]